It's not just Apple Inc. (AAPL) - Get Report , Nvidia Corporation (NVDA) - Get Report and FANG -- Facebook Inc (FB) - Get Report , Amazon.com, Inc. (AMZN) - Get Report , Netflix, Inc. (NFLX) - Get Report and Alphabet (GOOGL) - Get Report (GOOG) - Get Report -- that investors should be focusing on. They should also have their eyes on energy and biotech stocks. At least, according to these analysts.
The price target suggests upside of more than 36% from Wednesday's close of $43.79.
Then there's Abbott Laboratories (ABT) - Get Report . Analysts at Guggenheim initiated the company with a buy rating and slapped a $58 price target on the stock. The price target implies about 20% upside from Wednesday's closing price of $48.48.
Both Abbott and Anadarko have similar current prices and similar price targets from the analysts above. However, as you can see on the chart below, both have taken severely different paths to getting where they are.
With so much emphasis on tech stocks, it's easy to lose track of other sectors and industries. But clearly some analysts believe upside exists elsewhere. Need proof?
Will Pandora plunge 60% or soar 88%?
for the latest business headlines.
This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.